Torrent Pharmaceuticals Ltd

Meeting Details

• Date: 14-Aug-26; Meeting: Emkay Confluence 2026; Place: Mumbai; Type: Group and one-on-one.

Participants

• Company representatives (management) to participate.

Purpose

• Investor interaction under SEBI LODR regulations.

ESG rating update

• NSE Sustainability Ratings and Analytics Limited assigned Torrent Pharmaceuticals Ltd an ESG rating of 70.
• The update is under SEBI LODR Regulation 30 and related circular requirements.

Appointment of Additional Independent Director

• Shanti Ekambaram appointed as Additional Independent Director for 3-year term, effective 30 July 2026.
• Subject to shareholders' approval; she is not related to any other director.
• Not debarred by SEBI or any authority.

Listing update

• Final listing approvals from NSE and BSE received on 27 July 2026.
• 41,922,416 fully paid-up equity shares of ₹5 allotted to eligible JB Chemicals' shareholders.
• Record date for allotment: 17 July 2026.
• Listing and trading to commence on 28 July 2026.
• Scheme of Amalgamation with JB Chemicals consolidates into Torrent Pharmaceuticals.

Allotment under amalgamation

• Allotment of 4,19,22,416 Torrent shares to JB Chemicals shareholders on record date 17 July 2026.
• Exchange ratio: 51 Torrent shares per 100 JB Chemicals shares.
• Face value of new shares: ₹5 each.
• Post-allotment issued share capital increases to ₹1,90,18,39,280.
• Shares rank pari passu with existing equity.
• NCLT approved the Scheme of Amalgamation dated 6 July 2026.
• Securities Transfer and Stakeholders Relationship Committee approved allotment on 20 July 2026.

Dissolution of Philippines WOS

• Curatio Inc., Philippines, the WOS, has been voluntarily dissolved with effect from 10-Jul-2026.
• FY2025-26 turnover was Nil; net worth Rs 1.3 crore (0.02%).
• Dissolution effected by amendment to Articles of Incorporation; no sale consideration.
• Disclosure filed with exchanges under Regulation 30.

ESG rating update

• Crisil ESG Ratings assigns 'Crisil ESG 66' and 'Crisil Core ESG 74' to Torrent Pharmaceuticals

Meeting Details

• Date and time: 30 July 2026, 05:30 PM.
• Meeting type/mode: group teleconference (virtual) with investors/analysts.
• Organiser: Torrent Pharmaceuticals Limited.
• Event: Post Quarterly Financial Result Conference Call.
• Registration/Platform: Chorus Call Diamond Pass.

Participants

• Key participant: Company Secretary.

Purpose

• Purpose: discuss quarterly results for quarter ended 30 June 2026.

Meeting Details

• Board meeting on 30-Jul-2026; time and venue not disclosed.

Key Agenda Items

• Consider and approve unaudited standalone and consolidated financial results for quarter ended 30-Jun-2026.